Navigation Links
Perrigo Company to Attend the 2011 Annual Meeting of the American College of Allergy, Asthma & Immunology
Date:10/28/2011

ALLEGAN, Mich., Oct. 28, 2011 /PRNewswire/ -- Perrigo Company today announced that it will attend the 2011 Annual Meeting of the American College of Allergy, Asthma & Immunology Conference (ACAAI) Nov. 3-8 at the Hynes Convention Center and the Sheraton Boston Hotel in Boston.

The ACAAI is a professional medical organization that promotes excellence in the practice of the medical subspecialty of allergy and immunology.  It is comprised of more than 5,000 allergists, immunologists and primary care physicians who care for allergy patients across the nation.  

Perrigo is among the top pharmaceutical companies in the world and is the largest manufacturer of "store-brand" over-the-counter (OTC) medicines for the nation's leading retailers, grocers, club stores and pharmacy chains. The company produces an extensive portfolio of store-brand allergy products that compare to leading national-brands, such as Loratadine tablets (Claritin®), Cetirizine HCl tablets (Zyrtec®), and the most recent non-sedating antihistamine to switch from prescription to over-the-counter, Fexofenadine HCl tablets (Allegra® Allergy).  Perrigo's FDA-approved store-brand portfolio offers consumers savings of at least 20 percent over national-brands.STORE-BRAND VERSUS NATIONAL-BRAND SAVINGS ON OTC ALLERGY PRODUCTSNational-Brand**

Store-Brand **

Savings** 52-week periodLoratadine tablets (Claritin®) 30ct

$22.49

$9.85

$153.79Cetirizine HCl tablets (Zyrtec®) 30ct

$21.13

$13.95

$87.36Fexofenadine HCl tablets  (Allegra®) 45ct

$29.19

$20.69

$68.94In addition to offering a number of products in store-brand, Perrigo also offers a full ORx® portfolio (OTC medicines-by-prescription) for patients whose public or private healthcare insurance covers OTC products when they are prescribed by a doctor.  Unlike OTCs today, ORx® products are still eligible for pre-tax flexible spending account dollars, which can result in significant additional savings.  

Although most prescribers are somewhat familiar with store-brands, perceptions and knowledge of how they are manufactured varies widely. Attendance at the 2011 ACAAI conference gives Perrigo the opportunity to interact with these influential clinicians in a more intimate setting and educate them on the value and quality store-brands offer patients.  

"Perrigo has been actively engaging the medical community and having a dialogue about store-brands as part of the overall healthcare picture," said Joseph Papa, president and CEO of Perrigo. "It was through these conversations that we recognized the particular importance of highlighting our commitment to manufacturing products of exceptional quality. If we expect physicians to feel confident recommending store-brands to their patients, we know we must communicate that every Perrigo drug is held to the same regulatory and quality standards as national-brand drugs.  And once they learn more about our company and our products, many do recommend store-brands."

** Prices and savings based on national averages of major retailers. Actual prices may vary. (SymphonyIRI Group, 52 weeks ending 6/5/11). Calculations are based on per tablet pricing x 1 daily single dose for 365 days.  

About Perrigo CompanyPerrigo Company is a leading global healthcare supplier that develops, manufactures and distributes OTC and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, active pharmaceutical ingredients (API) and pharmaceutical and medical diagnostic products.  The Company is the world's largest store-brand manufacturer of OTC pharmaceutical products and infant formulas. The Company's primary markets and locations of manufacturing and logistics operations are the United States, Israel, Mexico, the United Kingdom and Australia. Visit Perrigo on the Internet (http://www.perrigo.com).
'/>"/>

SOURCE Perrigo Company
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Perrigo Reports Record Quarterly Revenue and Adjusted Earnings and Raises Full Year Adjusted EPS Guidance
2. Perrigo Company Announces Quarterly Dividend
3. Perrigo Expands Infant Formula Distribution in China With Founder Group
4. Perrigo Company Will Release First Quarter Fiscal 2012 Results On October 27, 2011
5. Perrigo Company Confirms FDA Tentative Approval for Clobetasol Propionate Emulsion Foam
6. Perrigo to Host Analyst Day on October 5, 2011 at the TASE, Tel Aviv Stock Exchange in Tel Aviv, Israel
7. Perrigo to Host Analyst Day on September 27, 2011 at the NASDAQ MarketSite in Times Square
8. Perrigo Announces FDA Final Approval for Ketoconazole Foam, 2%
9. Perrigo Company Will Release Fourth Quarter Fiscal 2011 Results on August 16, 2011
10. Watson Enters into Agreement to Acquire Products Related to Perrigos Acquisition of Paddock Laboratories
11. Perrigo Closes Acquisition of Paddock Labs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Oct. 11, 2017  Caris Life Sciences ® , ... the promise of precision medicine, today announced that St. ... Precision Oncology Alliance™ (POA) as its 17 th ... St. Jude Crosson Cancer Institute will help develop standards ... of tumor profiling, making cancer treatment more precise and ...
(Date:10/7/2017)... Texas , Oct. 6, 2017   Provista, ... with more than $100 billion in purchasing power, today ... news and information. The Newsroom is the ... and industry trends, infographics, expert bios, news releases, slideshows ... having access to a wealth of resources at their ...
(Date:10/2/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... , and named its founder as Diplomat,s chief information ... Tennessee , will operate under Diplomat subsidiary Envoy ... for health care partners to include IT outsourcing, consulting, ... "In an interoperable world, technology delivers comprehensive insight and ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to ... “patient engagement.” The patient is doing more than filling out a survey; in many ... is an increasing emphasis in health care and research on the importance of active ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health and Nutrition ... the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market ... can be easily incorporated into liquid products, while reducing costs to end users. , ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... most popular and least understood books in the Holy Scriptures, Revelation. The Book of ... baffled scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
Breaking Medicine News(10 mins):